These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1224 related articles for article (PubMed ID: 19197998)
41. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis]. Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444 [TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray. Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435 [TBL] [Abstract][Full Text] [Related]
44. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315 [TBL] [Abstract][Full Text] [Related]
45. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873 [TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids. Besig S; Voland P; Baur DM; Perren A; Prinz C Neuroendocrinology; 2009; 90(4):402-15. PubMed ID: 19816005 [TBL] [Abstract][Full Text] [Related]
47. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer. Li Q; Dong X; Gu W; Qiu X; Wang E Chin Med J (Engl); 2003 May; 116(5):727-30. PubMed ID: 12875690 [TBL] [Abstract][Full Text] [Related]
49. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638 [TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer. Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896 [TBL] [Abstract][Full Text] [Related]
51. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680 [TBL] [Abstract][Full Text] [Related]
52. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607 [TBL] [Abstract][Full Text] [Related]
53. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Inoshima N; Nakanishi Y; Minami T; Izumi M; Takayama K; Yoshino I; Hara N Clin Cancer Res; 2002 Nov; 8(11):3480-6. PubMed ID: 12429638 [TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138 [TBL] [Abstract][Full Text] [Related]
55. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294 [TBL] [Abstract][Full Text] [Related]
56. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Bremnes RM; Camps C; Sirera R Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975 [TBL] [Abstract][Full Text] [Related]
57. [Vascular endothelial growth factor in non-small cell lung carcinoma expression and its significance]. Yang G; Zhang L; Xie Y Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):104-5. PubMed ID: 11601013 [TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440 [TBL] [Abstract][Full Text] [Related]
59. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140 [TBL] [Abstract][Full Text] [Related]
60. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]